✦ LIBER ✦

Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: An ex vivo and in vitro longitudinal study in relapsing−remitting multiple sclerosis

✍ Scribed by Clara de Andrés; Carol Aristimuño; Virginia de las Heras; M Luisa Martínez-Ginés; Manuel Bartolomé; Rafael Arroyo; Joaquín Navarro; Santiago Giménez-Roldán; Eduardo Fernández-Cruz; Silvia Sánchez-Ramón

Book ID: 113729959
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 232 KB
Volume: 182
Category: Article
ISSN: 0165-5728
DOI: 10.1016/j.jneuroim.2006.09.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of IFN-ß therapy on the frequency

Effect of IFN-ß therapy on the frequency and function of CD4+CD25+ regulatory T cells and Foxp3 gene expression in relapsing–remitting multiple sclerosis (RRMS): A preliminary study

✍ Afshin Namdar; Behroz Nikbin; Mojde Ghabaee; Asghar Bayati; Maryam Izad 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 297 KB

Clinical response to interferon-β-1a may

Clinical response to interferon-β-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells: Differential role of circulating dendritic cells and CD4+ regulatory T-cells in relapsing–remitting multiple sclerosis: A 1-year longitudinal study

✍ Clara de Andrés; Carol Aristimuño; Manuel Bartolomé; Virginia de las Heras; Ma L 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 444 KB